NASDAQ:CABA

Cabaletta Bio Stock Predictions

etoro logo Buy CABA
*Your capital is at risk
$3.58
-0.100 (-2.72%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CABA Prediction Chart

CABA Predictions History

Latest community submissions for CABA.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 23, 2026 $3.00 +3.19% $2.90 X 96.45% 0
Feb 23, 2026 $2.85 -1.99% $2.90 V 98.34% 1
Feb 23, 2026 Bearish $2.90 V 1
Feb 20, 2026 $3.05 -2.84% $2.91 V 95.16% 1
Feb 20, 2026 $3.08 -1.78% $2.91 V 94.01% 1
Feb 20, 2026 Bullish $2.91 X 0
Feb 19, 2026 $3.04 -2.85% $3.14 X 96.84% 0
Feb 19, 2026 $3.07 -1.78% $3.14 X 97.91% 0
Feb 19, 2026 Bullish $3.14 V 1
Feb 18, 2026 $2.96 +0.00% $3.13 X 94.57% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CABA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CABALETTA BIO, INC.
Cabaletta Bio
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company's lead product candidate is DSG3-CAART,...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE